Kathleen Ford
Vermogen: 2 M $ op 30-06-2026
Vermogen: 2 M $ op 30-06-2026
Kathleen Ford is Chief Operating Officer at Kura Oncology, Inc. since 2019.
Formerly, Ms. Ford was Senior VP & Head-Global Clinical Operations at Merck Healthcare Germany GmbH from 2012 to 2017, Vice President-Clinical Operations at Millennium Pharmaceuticals, Inc. from 2002 to 2009, and Director-Clinical Operations at Alkermes Plc from 1993 to 2002.
Ms. Ford completed undergraduate education at Fitchburg State College.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
KURA ONCOLOGY, INC. 0,17% | 19-05-2026 | 153.560 ( 0,17% ) | 2 M $ | 30-06-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| KURA ONCOLOGY, INC. | Operationeel Directeur | 09-08-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Hoofd Techniek/Wetenschap/O&O | 01-01-2017 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Hoofd Techniek/Wetenschap/O&O | 01-01-2009 |
| ALKERMES PLC | Hoofd Techniek/Wetenschap/O&O | 01-01-2002 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 5 |
|---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines for oncology treatment | Health Technology |
Kura Oncology, Inc.
Kura Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company | Health Technology |
Fitchburg State College
Fitchburg State College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Merck Serono GmbH
Merck Serono GmbH Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceuticals products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau